Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11926670
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
granted -
US 11926830
Modulators of Complement Factor B
granted -
US 11925706
Manufacturing of bupivacaine multivesicular liposomes
granted -
US 11926584
Methods of making bempedoic acid and compositions of the same
granted -
US 11925689
Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same
granted -
US 11926828
Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1
granted -
US 11926832
Ketohexokinase (KHK) iRNA compositions and methods of use thereof
granted -
US 11926825
Compounds and methods for reducing ATXN2 expression
granted -
US 11926824
miRNA biogenesis in exosomes for diagnosis and therapy
granted -
US 11926632
Methods and compounds for restoring mutant p53 function
granted -
US 11925626
Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
granted -
US 11925675
Systemic delivery of adeno-associated virus vector expressing gamma-sarcoglycan and the treatment of muscular dystrophy
granted -
US 11925685
DNA antibody constructs encoding anti-ZIKV envelope antibodies
granted -
US 11926622
Fluoroalkyl-oxadiazoles and uses thereof
granted -
US 11925642
Regulation of eIF4E activity for migraine therapy
granted -
US 11925616
Compositions comprising urolithin compounds
granted -
US 11925654
Esters of 2-deoxy-monosaccharides with anti proliferative activity
granted -
US 11926826
Twist signaling inhibitor compositions and methods of using the same
granted -
US 11925669
Chinese herbal medicine composition having a function of reducing uric acid
granted -
US 11926676
Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such
granted -
US 11926656
Antibodies and methods for the diagnosis and treatment of Epstein Barr Virus infection
granted -
US 11926668
Anti-PD-1 antibodies for treatment of lung cancer
granted -
US 11925686
Materials for phototherapies of ophthalmic diseases
granted -
US 11925611
Use of ZT-1A and analogs thereof to prevent and/or treat neurodegenerative and neurocognitive disorders
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.